within Pharmacolibrary.Drugs.ATC.R;

model R06AA02
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.72,
    Cl             = 2.2166666666666666e-05,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0033,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.017166666666666667,
    Tlag           = 600,            
    Vdp             = 0.0021000000000000003,
    k12             = 1.5,
    k21             = 1.5
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R06AA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Diphenhydramine is a first-generation antihistamine with anticholinergic, antiemetic, and sedative properties. It is primarily used for the symptomatic relief of allergies, hay fever, common cold, insomnia, and as an antiemetic for motion sickness. It is approved and commonly used today as an over-the-counter medication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after a single oral administration.</p><h4>References</h4><ol><li><p>Redmond, JS, et al., &amp; Christensen, JM (2022). Pharmacokinetics of diphenhydramine following single-dose intravenous and oral administration in non-fasted adult horses. <i>Journal of veterinary pharmacology and therapeutics</i> 45(2) 188–195. DOI:<a href=&quot;https://doi.org/10.1111/jvp.13041&quot;>10.1111/jvp.13041</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34921427/&quot;>https://pubmed.ncbi.nlm.nih.gov/34921427</a></p></li><li><p>Ehling, S, et al., &amp; Papich, MG (2019). Diphenhydramine pharmacokinetics after oral and intravenous administration of diphenhydramine and oral administration of dimenhydrinate to healthy dogs, and pharmacodynamic effect on histamine-induced wheal formation: a pilot study. <i>Veterinary dermatology</i> 30(2) 91–e24. DOI:<a href=&quot;https://doi.org/10.1111/vde.12727&quot;>10.1111/vde.12727</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30779257/&quot;>https://pubmed.ncbi.nlm.nih.gov/30779257</a></p></li><li><p>Luna, BG, et al., &amp; Greenblatt, DJ (1989). Doxylamine and diphenhydramine pharmacokinetics in women on low-dose estrogen oral contraceptives. <i>Journal of clinical pharmacology</i> 29(3) 257–260. DOI:<a href=&quot;https://doi.org/10.1002/j.1552-4604.1989.tb03323.x&quot;>10.1002/j.1552-4604.1989.tb03323.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2723113/&quot;>https://pubmed.ncbi.nlm.nih.gov/2723113</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R06AA02;
